期刊文献+

绝经妇女外周血单个核细胞骨代谢调控因子表达变化 被引量:6

The bone metabolism-related factors expression in peripheral blood monocytes of postmenopausal women
下载PDF
导出
摘要 目的:探讨绝经妇女雌激素水平下降所致免疫细胞骨代谢调控因子变化。方法:纳入绝经妇女、未绝经妇女各30例,电化学发光法检测血清雌二醇(E2)水平;RT-PCR法检测外周血单个核细胞(PBMC)中雌激素受体(ERα、ERβ)、白细胞IL-6、TNFα-。核因子κB受体活化因子配基(RANKL)、核因子κB受体活化因子(RANK)mRNA表达;ELISA检测血清IL-6、TNFα-蛋白含量;双能X线骨密度仪检测腰椎2~4(L2-4)前后位骨密度(BMD)。结果:与未绝经组比较,绝经妇女E2水平明显下降,腰椎BMD显著降低(P〈0.05),外周血单个核细胞ERα、ERβmRNA表达明显降低(P〈0.05),IL-6、TNFα-、RANKL、RANKmRNA表达明显升高(P〈0.05),IL-6及TNFα-血清蛋白含量明显升高(P〈0.05)。相关性分析显示PBMC中ERα、ERβmRNA表达与血清E2水平、腰椎BMD呈显著正相关性(P〈0.05),PBMC中IL-6、TNFα-、RANKL、RANKmRNA表达与血清E2水平、腰椎BMD呈显著负相关性(P〈0.05)。结论:绝经后妇女雌激素水平下降伴随着外周血免疫细胞雌激素受体转录水平下降,同时,炎性骨吸收调控因子和溶骨性细胞因子表达升高,这种变化可能在绝经后骨丢失中发挥重要作用。 Objective:To analyze the expression of bone metabolism-related factors in peripheral blood monocytes of menopausal women.Methods:30 cases of postmenopausal women and 30 cases of premenopausal women were selected in this study.The serum estradiol(E2) was assessed by electrochemiluminescence immunoassay.Peripheral blood monocytes(PBMC) were isolated and ERα,ERβ,IL-6,TNF-α,RANKL,RANKmRNA were detected by RT-PCR.IL-6 and TNF-α protein contents were assessed by ELISA.Bone mineral density(BMD)of lumbar vertebrae 2-4 was measured with dual energy X ray absorptiometry.Results:Compared with premenopausal women,E2,BMD,ERα,ERβmRNA of postmenopausal women were decreased obviously(P0.05).However,the mRNA expression of IL-6,TNF-α,RANKL and RANK in PBMC of postmenopausal women were increased(P0.05).Meanwhile,the protein contents of IL-6 and TNFα were increased(P0.05).ERα,ERβmRNA in PBMC were positively correlated with serum E2 level and BMD(P0.05).IL-6 and TNF-α,RANKL,RANK mRNA in PBMC were negatively correlated with serum E2 level and BMD(P0.05).Conclusion:E2 level of postmenopausal women were decreased,and the expression of ERα,ERβ mRNA in PBMC were decreased synchronously.However,the expression of inflammatory bone metabolism-related factors and osteolytic factors were up-regulated at the same time.These changes may be attributable to the bone loss after menopause.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2011年第8期721-725,共5页 Chinese Journal of Immunology
基金 国家自然科学基金项目(No.30901918 30973807) 山东省博士基金项目(No.BS2009YY041) 山东省自然科学基金项目(No.ZR2010HQ066 ZR2010HQ043) 山东省计生委项目(No.[2009]8) 山东省中管局项目(No.2009-173)资助
关键词 绝经 雌激素 雌激素受体 骨代谢调控因子 Menopause Estrogen Estrogen receptor Metabolism-related factors
  • 相关文献

参考文献17

  • 1Pacifici R.The immune system and bone[J].Arch Biochem Biophys,2010;503(1):41-53.
  • 2Cutolo M,Brizzolara R,Atzeni F et al.The immunomodulatory effects of estrogens:clinical relevance in immune-mediated rheumatic diseases[J].Ann N Y Acad Sci,2010;1193:36-42.
  • 3Varenna M,Gatti D.The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis[J].Reumatismo,2010;62(3):163-171.
  • 4García-Pérez M A,Noguera I,Hermenegildo C et al.Alterations in the phenotype and function of immune cells in ovariectomy-induced osteopenic mice[J].Hum Reprod,2006;21(4):880-887.
  • 5王凌,李大金.免疫活性细胞对骨代谢的调控作用[J].中国免疫学杂志,2006,22(3):287-288. 被引量:4
  • 6王凌,李大金.细胞因子对骨代谢的调节作用[J].中华内分泌代谢杂志,2008,24(4):458-460. 被引量:1
  • 7Zallone A.Direct and indirect estrogen actions on osteoblasts and osteoclasts[J].Ann N Y Acad Sci,2006;1068:173-179.
  • 8Axmann R,Bhm C,Krnke G et al.Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo[J].Arthritis Rheum,2009;60(9):2747-2756.
  • 9Fuller K,Murphy C,Kirstein B et al.TNF-alpha potently activates osteoclasts,through a direct action independent of and strongly synergistic with RANKL[J].Endocrinology,2002;143:1108-1118.
  • 10Kobayashi K,Takahashi N,Jimi E et al.Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction[J].J Exp Med,2000;191:275-286.

二级参考文献136

  • 1Horton JE, Raisz LG, Simmons HA, et al. Bone resorbing activity in supematant fluid from cultured human peripheral blood leukocytes. Science, 1972,177:793-795.
  • 2Walsh MC, Kim N, Kadono Y, et al. Osteoimmunology : interplay between the immune system and bone metabolism. Annu Rev Immunol, 2006,24:33-63.
  • 3Arron JR,Choi Y. Bone versus immune system. Nature, 2000,408: 535 -536.
  • 4Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature, 2003,423:337-342.
  • 5Ross FP, Teitelbaum SL. alphavbeta3 and macrophage colonystimulating factor : partners in osteoclast biology. Immunol Rev, 2005, 208:88-105.
  • 6Tondravi MM, McKereher SR, Anderson K, et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU. 1. Nature, 1997, 386:81-84.
  • 7Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature, 1999,397:315-323.
  • 8Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature, 1999,402:304-309.
  • 9HikitaA, Yana I, Wakeyama H, et al. Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand. J Biol Chem, 2006,281:36846-36855.
  • 10Anderson DM, Markaskovsky E, Biilingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature, 1997,390 : 175-179.

共引文献12

同被引文献51

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部